Indocyanine Green Fluorescence Versus Blue Dye or Radioisotope Regarding Detection Rate of Sentinel Lymph Node Biopsy and Nodes Removed in Breast Cancer: A Systematic Review and Meta-Analysis

Overview

Journal Asian Pac J Cancer Prev

Specialty Oncology

Date 2020 May 28

PMID 32458621

Citations 19

Authors

Sarun Thongvitokomarn

Nuanphan Polchai

Affiliations

Soon will be listed here.

Abstract

Background: Either blue dye (BD) or radioisotope (RI) is mainly used for sentinel lymph node biopsy (SLNB) in breast cancer patients. Unlike the BD, RI has lower false-negative rate of SLNB. However, its lymphoscintigraphy, difficulty in preoperative injection, and undetected sentinel lymph nodes in some cases cause surgeons to rely only on BD. Currently, indocyanine green (ICG) fluorescence method (ICG-SLNB) is increasingly used as an alternative to the conventional mapping methods in many centers. This systematic review compared ICG with the conventional method of BD or RI in terms of detection rate of SLNB and the number of sentinel lymph nodes (SLNs) removed in.

Methods: We searched all relevant studies published between January 2000 and October 2019. All data on for evaluation of SLN detection rate, number of SLNs removed per patient, and tumor positive rate of SLNB were extracted.

Results: A total of 30 studies, including 4,216 SLN procedures were retrieved. There was a statistically significant difference between ICG and BD method in terms of SLN detection rate (OR, 6.73; 95% CI, 4.20-10.78). However, there was no significant difference between ICG and RI in this regard (OR, 0.90; 95% CI, 0.40-2.03). The number of SLNs removed per patient were 2.35 (1.46-5.4), 1.92 (1.0-3.64), and 1.72 (1.35-2.08) for ICG, BD, and RI, respectively. Only in 8 studies, the tumor positive rates in SLNB could be analyzed (ICG, 8.5-20.7%; BD, 12.7-21.4%; RI, 11.3-16%).

Conclusion: ICG-SLNB could be an additional or an alternative method for axillary node mapping in breast cancer.<br />.

Citing Articles

Feasibility of Non-Invasive Sentinel Lymph Node Identification in Early-Stage NSCLC Through Ultrasound Guided Intra-Tumoral Injection of Tc-Nanocolloid and Iodinated Contrast Agent During Navigation Bronchoscopy.

Ter Woerds D, Verhoeven R, Aarntzen E, van der Heijden E Cancers (Basel). 2024; 16(22).

PMID: 39594823 PMC: 11593123. DOI: 10.3390/cancers16223868.

Comparison of Indocyanine Green with conventional tracers for sentinel lymph node biopsy in breast cancer: A multidisciplinary evaluation of clinical effectiveness, safety, organizational and economic impact.

Pinelli M, Gerardi C, Lettieri E, Maioru M, Marone L, Bertoldi L PLoS One. 2024; 19(8):e0309336.

PMID: 39208241 PMC: 11361597. DOI: 10.1371/journal.pone.0309336.

Surgical margin status outcome of intraoperative indocyanine green fluorescence-guided laparoscopic hepatectomy in liver malignancy: a systematic review and meta-analysis.

Tangsirapat V, Kengsakul M, Udomkarnjananun S, Sookpotarom P, Rattanasakalwong M, Nuchanatanon J BMC Surg. 2024; 24(1):181.

PMID: 38867212 PMC: 11167816. DOI: 10.1186/s12893-024-02469-1.

A systematic review and meta-analysis of diagnostic performance of fluorescein-guided sentinel lymph node biopsy in early breast cancer.

Yadav S, Bharath S, Sharma D, Srivastava A, Jha C, Agarwal G Breast Cancer Res Treat. 2024; 206(1):19-30.

PMID: 38668856 DOI: 10.1007/s10549-024-07310-0.

New Alternative Techniques for Sentinel Lymph Node Biopsy.

Subramonian S, Chopra S, Vidya R Medicina (Kaunas). 2023; 59(12).

PMID: 38138180 PMC: 10744367. DOI: 10.3390/medicina59122077.

References

Mok C, Tan S, Zheng Q, Shi L . Network meta-analysis of novel and conventional sentinel lymph node biopsy techniques in breast cancer. BJS Open. 2019; 3(4):445-452. PMC: 6677105. DOI: 10.1002/bjs5.50157. View

Hokimoto N, Sugimoto T, Namikawa T, Funakoshi T, Oki T, Ogawa M . A Novel Color Fluorescence Navigation System for Intraoperative Transcutaneous Lymphatic Mapping and Resection of Sentinel Lymph Nodes in Breast Cancer: Comparison with the Combination of Gamma Probe Scanning and Visible Dye Methods. Oncology. 2017; 94(2):99-106. DOI: 10.1159/000484050. View

Sugie T, Kinoshita T, Masuda N, Sawada T, Yamauchi A, Kuroi K . Evaluation of the Clinical Utility of the ICG Fluorescence Method Compared with the Radioisotope Method for Sentinel Lymph Node Biopsy in Breast Cancer. Ann Surg Oncol. 2015; 23(1):44-50. DOI: 10.1245/s10434-015-4809-4. View

Papathemelis T, Jablonski E, Scharl A, Hauzenberger T, Gerken M, Klinkhammer-Schalke M . Sentinel Lymph Node Biopsy in Breast Cancer Patients by Means of Indocyanine Green Using the Karl Storz VITOM® Fluorescence Camera. Biomed Res Int. 2018; 2018:6251468. PMC: 5892256. DOI: 10.1155/2018/6251468. View

Rubinchik-Stern M, Shmuel M, Bar J, Eyal S, Kovo M . Maternal-fetal transfer of indocyanine green across the perfused human placenta. Reprod Toxicol. 2016; 62:100-5. DOI: 10.1016/j.reprotox.2016.04.017. View

Mieog J, Troyan S, Hutteman M, Donohoe K, van der Vorst J, Stockdale A . Toward optimization of imaging system and lymphatic tracer for near-infrared fluorescent sentinel lymph node mapping in breast cancer. Ann Surg Oncol. 2011; 18(9):2483-91. PMC: 3139732. DOI: 10.1245/s10434-011-1566-x. View

Sugie T, Sawada T, Tagaya N, Kinoshita T, Yamagami K, Suwa H . Comparison of the indocyanine green fluorescence and blue dye methods in detection of sentinel lymph nodes in early-stage breast cancer. Ann Surg Oncol. 2013; 20(7):2213-8. DOI: 10.1245/s10434-013-2890-0. View

Bezu C, Coutant C, Salengro A, Darai E, Rouzier R, Uzan S . Anaphylactic response to blue dye during sentinel lymph node biopsy. Surg Oncol. 2010; 20(1):e55-9. DOI: 10.1016/j.suronc.2010.10.002. View

Guo W, Zhang L, Ji J, Gao W, Liu J, Tong M . Evaluation of the benefit of using blue dye in addition to indocyanine green fluorescence for sentinel lymph node biopsy in patients with breast cancer. World J Surg Oncol. 2014; 12:290. PMC: 4182872. DOI: 10.1186/1477-7819-12-290. View

10.

Rudolf H, Goretzlehner G, BRUGMANN E, Towe J, Rudolf K . [Assessment of liver function using indocyanine green (Ujoviridin) during normal pregnancy, during labor and in puerperium]. Zentralbl Gynakol. 1977; 99(25):1548-53. View

11.

Kitai T, Inomoto T, Miwa M, Shikayama T . Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer. 2005; 12(3):211-5. DOI: 10.2325/jbcs.12.211. View

12.

Zhang X, Li Y, Zhou Y, Mao F, Lin Y, Guan J . Diagnostic Performance of Indocyanine Green-Guided Sentinel Lymph Node Biopsy in Breast Cancer: A Meta-Analysis. PLoS One. 2016; 11(6):e0155597. PMC: 4900647. DOI: 10.1371/journal.pone.0155597. View

13.

Guo W, Zhang L, Ji J, Gao W, Liu J, Tong M . Breast cancer sentinel lymph node mapping using near-infrared guided indocyanine green in comparison with blue dye. Tumour Biol. 2013; 35(4):3073-8. DOI: 10.1007/s13277-013-1399-2. View

14.

Motomura K, Komoike Y, Hasegawa Y, Kasugai T, Inaji H, Noguchi S . Intradermal radioisotope injection is superior to subdermal injection for the identification of the sentinel node in breast cancer patients. J Surg Oncol. 2003; 82(2):91-6; discussion 96-7. DOI: 10.1002/jso.10200. View

15.

Tagaya N, Yamazaki R, Nakagawa A, Abe A, Hamada K, Kubota K . Intraoperative identification of sentinel lymph nodes by near-infrared fluorescence imaging in patients with breast cancer. Am J Surg. 2008; 195(6):850-3. DOI: 10.1016/j.amjsurg.2007.02.032. View

16.

Sugie T, Ikeda T, Kawaguchi A, Shimizu A, Toi M . Sentinel lymph node biopsy using indocyanine green fluorescence in early-stage breast cancer: a meta-analysis. Int J Clin Oncol. 2016; 22(1):11-17. DOI: 10.1007/s10147-016-1064-z. View

17.

Chang Y, Lee H, Lee C, Jung S, Kim W, Woo S . Sentinel lymph node detection using fluorescein and blue light-emitting diodes in patients with breast carcinoma: A single-center prospective study. Asian J Surg. 2019; 43(1):220-226. DOI: 10.1016/j.asjsur.2019.03.005. View

18.

Latosinsky S, Dabbs K, Moffat F . Canadian Association of General Surgeons and American College of Surgeons Evidence-Based Reviews in Surgery. 27. Quality-of-life outcomes with sentinel node biopsy versus standard axillary treatment in patients with operable breast cancer..... Can J Surg. 2008; 51(6):483-5. PMC: 2592588. View

19.

Tong M, Guo W, Gao W . Use of Fluorescence Imaging in Combination with Patent Blue Dye versus Patent Blue Dye Alone in Sentinel Lymph Node Biopsy in Breast Cancer. J Breast Cancer. 2014; 17(3):250-5. PMC: 4197355. DOI: 10.4048/jbc.2014.17.3.250. View

20.

Robson S, Mutch E, Boys R, Woodhouse K . Apparent liver blood flow during pregnancy: a serial study using indocyanine green clearance. Br J Obstet Gynaecol. 1990; 97(8):720-4. DOI: 10.1111/j.1471-0528.1990.tb16246.x. View